Canadian Pharma, Biotech and Life Sciences Stocks

Organigram is ready for a breakout, Beacon says

Beacon Securities analyst Russell Stanley continues to be bullish on Organigram Holdings (Organigram Holdings Stock Quote, Chart News TSX:OGI), saying that the Moncton, New Brunswick, cannabis company looks ready for a breakout. On Monday, Organigram reported that it had received Health Canada appr ...

Canopy Growth Corp has never been in better shape, Mark Zekulin says

Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart, News TSX:WEED) may be in search mode for a new CEO at the moment but Mark Zekulin has nothing but praise for his company. There has been a gloomy picture painted by WEED’s share price of late, but the current CEO thinks Canopy is in great ...

Five Canadian pot stocks to buy for triple-digit returns in 2020

Canadian pot stocks. Dead money? The clouds have moved in over the Canadian cannabis space. Lackluster results from presumptive leader Canopy Growth Corp and a full-blown scandal via CannTrust Holdings have combined with a hundred smaller cuts to sink the returns for hot money investors used to wha ...

Biotech penny stock Antibe Therapeutics has a huge upside: Echelon

Echelon Wealth Partners analyst Douglas Loe is holding steady on his investment thesis for clinical stage drug developer Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart, News TSXV:ATE), maintaining in a client update on Wednesday his “Speculative Buy” recommendation and $1.40 target ...

Raymond James launches coverage of Profound Medical Corp with a $4.00 target

Raymond James analyst Rahul Sarugaser thinks Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) is profoundly undervalued. In a research report to clients today, the analyst initiated coverage of the Toronto-based medical device company with an “Outperform” rating an ...

Answers to popular stock and investing questions this week

This week we look at some of the most popular questions in the 5i Research question and answer service featuring Canopy Growth, Preferred Shares, and high interest savings accounts. ...

Profound Medical is ready for a breakout, says Mackie Research

Investors should soon expect a breakout for Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) after the company’s just-received FDA clearance for its TULSA-PRO medical device, says analyst Andre Uddin with Mackie Research Capital Corporation. The analyst provided an u ...

Canopy Growth Corp has lost its lead, GMP says

Following a quarter that came in softer than expected, GMP Securities analyst Ryan Macdonell has cut his price target on Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart, News TSX:WEED) On Wednesday, Canopy reported its Q1, 2020 results. The company lost $1.28-billion on net revenue of $90 ...

Canopy Growth Corp has price target slashed at PI

Canadian cannabis licensed producer Canopy Growth  (Canopy Growth  Corp Stock Quote, Chart, News TSE:WEED) got a big target price cut from PI Financial’s Jason Zandberg on the back of the company’s disappointing quarterly report. In an earnings update on Thursday, Zandberg kept his “Buy” ...

ProMetic Life Sciences has price target slashed at Echelon

Considerable losses and extended timelines for drug approval are keeping ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart, News TSX:PLI) a “Hold” for analyst Douglas Loe of Echelon Wealth Partners, who in a client update on Tuesday dropped his price target from $15.00 to $9.25 ...